RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sequana Medical Stock

Sequana Medical ROE 2024

Sequana Medical ROE

1.67

Ticker

SEQUA.BR

ISIN

BE0974340722

WKN

A2PD78

In 2024, Sequana Medical's return on equity (ROE) was 1.67, a -88.29% increase from the 14.29 ROE in the previous year.

Sequana Medical Aktienanalyse

What does Sequana Medical do?

Sequana Medical NV is a company specialized in the development of innovative medical devices to treat and improve patients worldwide. The company was founded in Switzerland in 2006 and is headquartered in Ghent, Belgium. Sequana Medical has two main business areas: the spinaX therapy for chronic lower back pain and the alfapump system for the treatment of ascites. The spinaX therapy is an innovative medical device that treats chronic lower back pain. It is a minimally invasive therapy in which a small device is implanted in the back to stimulate the patients using electricity. This type of therapy is widely recognized and in many cases achieves significant pain relief and improvement in quality of life. The spinaX therapy is currently available in Europe and has already achieved positive results. The second main product of Sequana Medical is the alfapump system, which was specifically developed for the treatment of ascites. Ascites is an accumulation of fluid in the abdomen that can occur due to liver diseases and other causes. The alfapump system is an innovative medical device that allows for continuous drainage of the abdomen without the need for multiple punctures of the patient. The continuous drainage of the abdominal cavity improves quality of life and can also shorten hospital stays. The alfapump system has been approved as a medical device in Europe and is currently available in several European countries. Sequana Medical has undergone excellent development in recent years. The company has successfully completed several financing rounds and is expanding its international network through partnerships with other pharmaceutical and medical companies. Currently, Sequana Medical is actively working on expanding its products and services on a global level. Overall, Sequana Medical is an innovative company specialized in the development and marketing of innovative medical devices. The spinaX therapy and the alfapump system are examples of the innovation and excellence that characterize Sequana Medical. Therefore, it can be assumed that the company will continue its success in the future and play a crucial role in the medical sector. Sequana Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Sequana Medical's Return on Equity (ROE)

Sequana Medical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Sequana Medical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Sequana Medical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Sequana Medical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Sequana Medical stock

What is the ROE (Return on Equity) of Sequana Medical this year?

The ROE of Sequana Medical this year is 1.67 undefined.

How has the Return on Equity (ROE) of Sequana Medical developed compared to the previous year?

The ROE of Sequana Medical has increased by -88.29% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Sequana Medical?

A high ROE indicates that Sequana Medical generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Sequana Medical?

A low ROE can indicate that Sequana Medical is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Sequana Medical affect the company?

A change in ROE (Return on Equity) of Sequana Medical can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Sequana Medical?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Sequana Medical?

Some factors that can influence Sequana Medical's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Sequana Medical pay?

Over the past 12 months, Sequana Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sequana Medical is expected to pay a dividend of 0 EUR.

What is the dividend yield of Sequana Medical?

The current dividend yield of Sequana Medical is .

When does Sequana Medical pay dividends?

Sequana Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sequana Medical?

Sequana Medical paid dividends every year for the past 0 years.

What is the dividend of Sequana Medical?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sequana Medical located?

Sequana Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sequana Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sequana Medical from 9/21/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did Sequana Medical pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of Sequana Medical in the year 2023?

In the year 2023, Sequana Medical distributed 0 EUR as dividends.

In which currency does Sequana Medical pay out the dividend?

The dividends of Sequana Medical are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sequana Medical

Our stock analysis for Sequana Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sequana Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.